Plain-English translation of NCT05373823 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Melanoma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an online tool called MySmartSkin that teaches melanoma survivors how to check their skin thoroughly for signs of new or returning cancer. The tool was designed with input from patients, doctors, and other healthcare experts. Researchers want to see if this tool helps survivors perform better skin self-exams and make healthier sun protection choices compared to a standard educational website.
Melanoma survivors need to check their skin regularly to catch new cancers or recurrences early, when they're most treatable. Many survivors don't perform these self-exams as thoroughly as they should. This trial exists to test whether a personalized online tool can help more survivors do these important checks and adopt better sun safety habits.
You likely qualify if…
You likely don't qualify if…
The trial runs for about four years. First, researchers will spend 15 months improving the MySmartSkin tool based on feedback from patients and doctors. Then, you'll be randomly assigned to either use the enhanced MySmartSkin tool or visit a standard educational website about skin self-exams. Over the next few years, researchers will track how well you perform skin self-exams, your sun protection behaviors, and whether any new skin cancers develop. You'll also share your thoughts on how easy and helpful the tool is to use.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States